Abstract
Four hydroxyl groups of pyripyropenes have been modified and evaluated for their ability to inhibit microsomal acyl-CoA: cholesterol acyltransferase (ACAT) activity in vitro and to lower cholesterol absorption in vivo in a cholesterol-fed hamster. 7-O-n-Valeryl derivative (8c) improved the in vitro ACAT inhibitory activity (IC50 = 13 nM) about 7 times better than pyripyropene A. Introduction of methanesulfonyl group at 11-hydroxyl group (17a) increased both in vitro activity(IC50 = 19 nM) and in vivo efficacy (ED50 = 10 mg/kg).
Original language | English |
---|---|
Pages (from-to) | 1133-1148 |
Number of pages | 16 |
Journal | Journal of Antibiotics |
Volume | 49 |
Issue number | 11 |
DOIs | |
Publication status | Published - 1996 |
ASJC Scopus subject areas
- Pharmacology
- Drug Discovery